Your browser doesn't support javascript.
loading
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study.
Smit, Colette; Boyd, Anders; Rijnders, Bart J A; van de Laar, Thijs J W; Leyten, Eliane M; Bierman, Wouter F; Brinkman, Kees; Claassen, Mark A A; den Hollander, Jan; Boerekamps, Anne; Newsum, Astrid M; Schinkel, Janke; Prins, Maria; Arends, Joop E; Op de Coul, Eline L M; van der Valk, Marc; Reiss, Peter.
Afiliación
  • Smit C; Stichting HIV Monitoring, Amsterdam, Netherlands.
  • Boyd A; Stichting HIV Monitoring, Amsterdam, Netherlands; Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, Netherlands. Electronic address: a.c.boyd@amsterdamumc.nl.
  • Rijnders BJA; Department of Internal Medicine, Section Infectious Diseases, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
  • van de Laar TJW; Department of Donor Medicine Research, Laboratory of Blood-borne Infections, Sanquin Research and Laboratory of Medical Microbiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
  • Leyten EM; Department of Internal Medicine and Infectious Diseases, Medical Centre Haaglanden, Den Haag, Netherlands.
  • Bierman WF; University of Groningen, Department of Internal Medicine, Section Infectious Diseases, University Medical Centre Groningen, Groningen, Netherlands.
  • Brinkman K; Department of Internal Medicine and Infectious Diseases, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
  • Claassen MAA; Department of Internal Medicine and Infectious Diseases, Rijnstate Ziekenhuis, Arnhem, Netherlands.
  • den Hollander J; Department of Internal Medicine and Infectious Diseases, Maasstad Ziekenhuis, Rotterdam, Netherlands.
  • Boerekamps A; Department of Internal Medicine, Section Infectious Diseases, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
  • Newsum AM; Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, Netherlands; Department of Infectious Diseases, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
  • Schinkel J; Department of Medical Microbiology, Section of Clinical Virology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
  • Prins M; Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, Netherlands; Department of Infectious Diseases, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
  • Arends JE; Department of Internal Medicine and Infectious Diseases, Universitair Medisch Centrum Utrecht, Utrecht, Netherlands.
  • Op de Coul ELM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • van der Valk M; Department of Infectious Diseases, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
  • Reiss P; Stichting HIV Monitoring, Amsterdam, Netherlands; Department of Infectious Diseases, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Lancet HIV ; 8(2): e96-e105, 2021 02.
Article en En | MEDLINE | ID: mdl-33357835

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Infecciones por VIH / Abuso de Sustancias por Vía Intravenosa / VIH-1 / Hepacivirus / Hepatitis C Crónica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet HIV Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Infecciones por VIH / Abuso de Sustancias por Vía Intravenosa / VIH-1 / Hepacivirus / Hepatitis C Crónica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet HIV Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos